AC T02105
XX
ID T02105
XX
DT 03.03.1997 (created); ewi.
DT 24.04.2015 (updated); sup.
CO Copyright (C), QIAGEN.
XX
FA C/EBPbeta-LAP
XX
SY C/EBPbeta(p34); C/EBPbeta2; CCAAT/enhancer binding protein (C/EBP), beta; CEBPB; IL6DBP; LAP; NF-IL6; p34(C/EBPbeta); TCF5.
XX
OS rat, Rattus norvegicus
OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; rodentia; myomorpha; muridae; murinae
XX
GE G013627 Cebpb.
XX
CL C0008; bZIP.
XX
SZ 276 AA; 29.2 kDa (cDNA) (calc.), 34 kDa (SDS) [1]
XX
SQ MEVANFYYEPDCLAYGAKAARAAPRAPAAEPAIGEHERAIDFSPYLEPLAPAAADFAAPA
SQ PAHHDFLSDLFADDYGAKPSKKPSDYGYVSLGRAGAKAAPPACFPPPPPAALKAEPGFEP
SQ ADCKRADDAPAMAAGFPFALRAYLGYQATPSGSSGSLSTSSSSSPPGTPSPADAKAAPAA
SQ CFAGPPAAPAKAKAKKAVDKLSDEYKMRRERNNIAVRKSRDKAKMRNLETQHKVLELTAE
SQ NERLQKKVEQLSRELSTLRNLFKQLPEPLLASAGHC
XX
SC edited Swiss-Prot #P21272
XX
FT 1 10 
activation domain module 1 (ADM1) [2].
FT 33 51 
activation domain module 2 (ADM2) [2].
FT 63 72 
activation domain module 3 (ADM3) [2].
FT 116 149 
regulatory domain 1 (RD1) [2].
FT 163 191 
regulatory domain 2 (RD2) [2].
FT 200 264 
SM00338; brlzneu.
FT 201 254 
PF07716; Basic region leucine zipper.
FT 202 265 
PS50217; BZIP.
XX
SF alternative translation initiation product to C/EBPbeta [1];
SF RD1 is a powerful inhibitory domain [2];
SF RD2 represses DNA-binding specifically in fibroblast-like cells (L cell line) [2];
XX
FF activating and repressing properties [1] [2];
XX
IN T05452 BAF155; human, Homo sapiens.
IN T05499 BAF47; human, Homo sapiens.
IN T05451 BRG1; human, Homo sapiens.
IN T01261 Brm; human, Homo sapiens.
IN T00459 C/EBPbeta-FL; rat, Rattus norvegicus.
IN T01420 C/EBPbeta-LIP; rat, Rattus norvegicus.
XX
MX M00109 V$CEBPB_01.
MX M00117 V$CEBPB_02.
MX M07315 V$CEBPB_Q3.
MX M01896 V$CEBPB_Q6.
MX M00912 V$CEBP_Q2_01.
MX M00770 V$CEBP_Q3.
XX
BS R60572.
BS R60573.
BS R59480.
BS R58214.
BS R58215.
BS R58216.
BS R58217.
BS R58218.
BS R58222.
BS R58225.
BS R58226.
BS R58227.
BS R58228.
BS R58229.
BS R58230.
BS R58231.
BS R58237.
BS R63552.
BS R34472.
BS R67365.
BS R01344.
XX
DR TRANSPATH: MO000026168.
DR UniProtKB: P21272-2;
XX
RN [1]; RE0002865.
RX PUBMED: 1934061.
RA Descombes P., Schibler U.
RT A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA
RL Cell 67:569-579 (1991).
RN [2]; RE0003538.
RX PUBMED: 7621830.
RA Williams S. C., Baer M., Dillner A. J., Johnson P. F.
RT CRP2 (C/EBPbeta) contains a bipartite regulatory domain that controls transcriptional activation, DNA binding and cell specificity
RL EMBO J. 14:3170-3183 (1995).
RN [3]; RE0007055.
RX PUBMED: 8007984.
RA Sears R. C., Sealy L.
RT Multiple forms of C/EBP beta bind the EFII enhancer sequence in the Rous sarcoma virus long terminal repeat
RL Mol. Cell. Biol. 14:4855-4871 (1994).
XX
//